» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing


More Information on Ethics and Clinical Trials

Letter in the Washington Post on Death of Jesse Gelsinger in Study

This letter, by Health Research Group Deputy Director Peter Lurie, M.D., MPH, appeared in the Washington Post on February 14, 2000.

The death of Jesse Gelsinger in the University of Pennsylvania gene therapy study raises the issue of reporting adverse events in clinical trials. Researchers are required to report adverse events in all clinical trials for experimental drugs to the Food and Drug Administration (FDA). Debate rages over whether gene therapy investigators should be required to report such events to the National Institutes of Health, which can disclose these events to the public, in addition to reporting them to the FDA, which cannot. This question evades the real issue: the failure of the FDA to disclose adverse events in all clinical trials. The FDA is charged with preserving the public health, not with protecting drug companies from investors who might desert them if they learned that an experimental drug "has some toxicity.  One cannot conduct quality or ethical research in an environment in which other scientists' experiences are hidden. Denying information can be hazardous; this may be the real lesson of the Gelsinger episode.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.